SCHEMBL130475

SCHEMBL130475

O=C(C=Cc1ccccc1O)c1ccccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 1.00
GUSB P08236 1/20 1.00
MAOB P27338 4/20 0.75
CHRNA7 P36544 4/20 0.73
AR P10275 5/20 0.69
MAPT P10636 2/20 0.68
CYP2C19 P33261 1/20 0.68
NFKB1 P19838 2/20 0.66
JUN P05412 1/20 0.66
NFE2L2 Q16236 1/20 0.66
KDM4E B2RXH2 1/20 0.64
MEN1 O00255 1/20 0.64
ALDH1A1 P00352 1/20 0.64
TP53 P04637 1/20 0.64
CYP3A4 P08684 1/20 0.64
HPGD P15428 1/20 0.64
ALOX15 P16050 1/20 0.64
ALOX12 P18054 1/20 0.64
MAOA P21397 1/20 0.64
MAPK1 P28482 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660339 1.00 BCHE (1.00) BCHEGUSBMAOBCHRNA7AR
SCHEMBL30791478 0.90 BCHE (0.81) BCHEGUSBMAOBCHRNA7AR
SCHEMBL11595805 0.87 BCHE (0.77) BCHEGUSBMAOBCHRNA7AR
SCHEMBL1649380 0.87 BCHE (0.77) BCHEGUSBMAOBCHRNA7AR
SCHEMBL471832 0.87 BCHE (0.77) BCHEGUSBMAOBCHRNA7AR
SCHEMBL8106959 0.86 BCHE (0.75) BCHEGUSBMAOBCHRNA7AR
SCHEMBL6699827 0.86 BCHE (0.75) BCHEGUSBMAOBCHRNA7AR
SCHEMBL675698 0.86 BCHE (0.75) BCHEGUSBMAOBCHRNA7AR
SCHEMBL6699830 0.86 BCHE (0.75) BCHEGUSBMAOBCHRNA7AR
SCHEMBL3611920 0.86 BCHE (0.75) BCHEGUSBMAOBCHRNA7AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260096569-A1 EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES APEEL TECH INC (US) 2026-04-09 US claimed
EP-4496476-A1 GAS PHASE TREATMENT OF PRODUCE Apeel Technology, Inc. (US) 2025-01-29 EP claimed
WO-2023183341-A1 GAS PHASE TREATMENT OF PRODUCE APEEL TECHNOLOGY, INC. (US) 2023-09-28 WO claimed
US-20220330565-A1 EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES APEEL TECHNOLOGY, INC. 2022-10-20 US claimed
US-20100279987-A1 COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF SALIOU CLAUDE 2010-11-04 US claimed
EP-2054046-A2 COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF Johnson and Johnson Consumer Companies, Inc. (US) 2009-05-06 EP claimed
WO-2008019212-A2 COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF JOHNSON & JOHNSON CONSUMER COMPANIES, INC. (US) 2008-02-14 WO claimed
US-20080032938-A1 COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF JOHNSON & JOHNSON CONSUMER INC. 2008-02-07 US claimed
US-20260096569-A1 EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES APEEL TECH INC (US) 2026-04-09 US disclosed
EP-4262528-B1 DEVICE AND METHOD FOR CONTINUOUS EVEN APPLICATION OF COMPOSITION TO SKIN KENVUE BRANDS LLC (US) 2026-02-18 EP disclosed
US-20260033492-A1 Pest Repellents and Uses Thereof SENSORYGEN INC (US) 2026-02-05 US disclosed
EP-4340807-B1 HAIR COLOR COMPOSITIONS FOR MITIGATING COLOR LOSS LUBRIZOL ADVANCED MAT INC (US) 2026-01-28 EP disclosed
US-12472336-B2 System and method for selective application of cosmetic composition to impart undereye brightening KENVUE BRANDS LLC (US) 2025-11-18 US disclosed
US-12377042-B2 Botanical and bacterial extracts displaying retinol-like activity KENVUE BRANDS LLC (US) 2025-08-05 US disclosed
WO-2000062743-A2 SKIN CARE COMPOSITIONS CONTAINING COMBINATION OF SKIN CARE ACTIVES THE PROCTER & GAMBLE COMPANY (US) 2000-10-26 WO disclosed
WO-2000042961-A2 WATER-FLUX LIMITING CLEANSING ARTICLES THE PROCTER & GAMBLE COMPANY (US) 2000-07-27 WO disclosed
US-6093411-A AN EMULSION COMPRISING FLAVONOIDS FOR PREVENTING OR TREATING SKIN DISORDERS THE PROCTER & GAMBLE COMPANY (US) 2000-07-25 US disclosed
US-6051602-A METHODS FOR PREVENTION OR TREATING SKIN DISORDERS USING FLAVONOID COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2000-04-18 US disclosed
WO-1999047113-A1 COMPOSITIONS FOR REGULATING SKIN APPEARANCE THE PROCTER & GAMBLE COMPANY (US) 1999-09-23 WO disclosed
WO-1999037652-A1 TRICYCLIC INDOLENE SUBSTITUTED OXAZOLIDINONES BAYER AKTIENGESELLSCHAFT (DE) 1999-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12377042-B2 Botanical and bacterial extracts displaying retinol-like activity LRAT, GLA, RBP4 BCHE 2361/4885GUSB 11/4885MAOB 964/4885
US-20080032938-A1 COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF CYP17A1, HSD17B7, CUTA BCHE 2682/4885GUSB 1539/4885MAOB 2564/4885
US-20260033492-A1 Pest Repellents and Uses Thereof F3, TFPI, FLI1 BCHE 641/4885GUSB 4388/4885MAOB 1790/4885
US-20100279987-A1 COMPOSITIONS CONTAINING CHALCONES AND USE THEREOF CYP17A1, HSD17B7, CUTA BCHE 2682/4885GUSB 1539/4885MAOB 2564/4885
US-20260096569-A1 EDIBLE COATING WITH ANTIMICROBIAL PROPERTIES CYP51A1, ERG28, NISCH BCHE 2458/4885GUSB 559/4885MAOB 1312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.